Skip to main content
SpringerLink
Log in

Electrocardiograms Not to Miss

  • Chapter
  • First Online:
Clinical Approach to Sudden Cardiac Death Syndromes

  • 1292 Accesses

Abstract

Brugada syndrome (BrS) is characterized by a typical electrocardiographic pattern of ST segment elevation in leads V1-V3.1 Patients with BrS are at increased risk of sudden cardiac death (SCD) as a result of very fast polymorphic ventricular tachyarrhythmia (PVT)/ventricular fibrillation (VF). Both repolarization and depolarization abnormalities, especially in the RVOT, constitute the hallmark of BrS.2,3

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sovari AA, Prasun MA, Kocheril AG. ST segment elevation on electrocardiogram: the electrocardiographic pattern of Brugada syndrome. MedGenMed. 2007;9:59

    PubMed  Google Scholar 

  2. Hisamatsu K, Kusano KF, Morita H, et al. Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps. J Cardiovasc Electrophysiol. 2004;15:870-876

    Article  PubMed  Google Scholar 

  3. Morita H, Zipes DP, Morita ST, Wu J. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome. Heart Rhythm. 2007;4:66-74

    Article  PubMed  Google Scholar 

  4. Torres PI, Nava S, Gómez-Flores J, et al. Association of congenital, diffuse electrical disease in children with normal heart: sick sinus syndrome, intraventricular conduction block, and monomorphic ventricular tachycardia. J Cardiovasc Electrophysiol. 2008;19(5):550-555

    Article  Google Scholar 

  5. Probst V, Denjoy I, Meregalli PG, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation. 2007;115:2042-2048

    Article  PubMed  Google Scholar 

  6. Yokokawa M, Noda T, Okamura H, et al. Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Am J Cardiol. 2007;100: 649-655

    Article  CAS  PubMed  Google Scholar 

  7. Bigi MA, Aslani A, Shahrzad S. Clinical predictors of atrial fibrillation in Brugada syndrome. Europace. 2007;9: 947-950

    Article  PubMed  Google Scholar 

  8. Takagi M, Yokoyama Y, Aonuma K, Aihara N, Hiraoka M; Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with Brugada syndrome: multicenter study in Japan. Cardiovasc Electro­physiol. 2007;18:1244-1251

    Google Scholar 

  9. Junttila MJ, Brugada P, Hong K, et al. Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients. J Cardiovasc Electrophysiol. 2008;19(4):380-383

    Article  PubMed  Google Scholar 

  10. Babai Bigi MA, Aslani A, Shahrzad S. aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome. Heart Rhythm. 2007;4:1009-1012

    Google Scholar 

  11. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA; Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002;106:2514-2519

    Google Scholar 

  12. Cau C. The Brugada syndrome. A predicted sudden juvenile death. Minerva Med. 1999;90:359-364

    CAS  PubMed  Google Scholar 

  13. Junttila MJ, Raatikainen MJ, Perkiomaki JS, Hong K, Brugada R, Huikuri HV. Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J. 2007;28: 463-468

    Article  PubMed  Google Scholar 

  14. Tada T, Kusano KF, Nagase S, et al. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2008;19:56-61

    Article  PubMed  Google Scholar 

  15. Nishizaki M, Fujii H, Sakurada H, Kimura A, Hiraoka M. Spontaneous T wave alternans in a patient with Brugada syndrome-responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing. J Cardiovasc Electrophysiol. 2005;16:217-220

    Article  PubMed  Google Scholar 

  16. Morita H, Zipes DP, Lopshire J, Morita ST, Wu J. T wave alternans in an in vitro canine tissue model of Brugada syndrome. Am J Physiol Heart Circ Physiol. 2006;291: H421-H428

    Article  Google Scholar 

  17. Bezzina C, Veldkamp MW, van Den Berg MP, et al. A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res. 1999;85:1206-12013

    CAS  PubMed  Google Scholar 

  18. Mizumaki K, Fujiki A, Nishida K, et al. Bradycardia-dependent ECG changes in Brugada syndrome. Circ J. 2006; 70:896-901

    Article  PubMed  Google Scholar 

  19. Pitzalis MV, Anaclerio M, Iacoviello M, et al. Rizzon P QT-interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome. J Am Coll Cardiol. 2003;42:1632-1637

    Article  PubMed  Google Scholar 

  20. Antzelevitch C, Pollevick GD, Cordeiro JM, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115:442-449

    Article  PubMed  Google Scholar 

  21. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 1992;20:1391-1396

    Article  CAS  PubMed  Google Scholar 

  22. Zareba W, Moss AJ, le Cessie S, Hall WJ. T wave alternans in idiopathic long QT syndrome. J Am Coll Cardiol. 1994;23: 1541-1546

    Article  CAS  PubMed  Google Scholar 

  23. Mönnig G, Eckardt L, Wedekind H, et al. Electrocardiographic risk stratification in families with congenital long QT syndrome. Eur Heart J. 2006;27:2074-2080

    Article  PubMed  Google Scholar 

  24. Shimizu W, Noda T, Takaki H, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm. 2004;1: 276-283

    Article  PubMed  Google Scholar 

  25. Denjoy I, Lupoglazoff JM, Villain E, et al. The Jervell and Lange-Nielsen syndrome. Natural history, molecular basis and clinical outcome. Arch Mal Coeur Vaiss. 2007;100:359-364

    CAS  PubMed  Google Scholar 

  26. Zareba W. Drug induced QT prolongation. Cardiol J. 2007; 14:523-535

    PubMed  Google Scholar 

  27. Noda T, Shimizu W, Satomi K, et al. Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome. Eur Heart J. 2004;25: 2149-2154

    Article  PubMed  Google Scholar 

  28. Syrris P, Ward D, Asimaki A, et al. Clinical expression of Plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation. 2006;113:356-364

    Article  CAS  PubMed  Google Scholar 

  29. Nasir K, Tandri H, Rutberg J, et al. Filtered QRS duration on signal-averaged electrocardiography predicts inducibility of ventricular tachycardia in arrhythmogenic right ventricle dysplasia. Pacing Clin Electrophysiol. 2003;26:1955-1960

    Article  PubMed  Google Scholar 

  30. Gregor P. Electrocardiography in cardiomyopathies. Vnitr Lek. 2003;49:727-729

    CAS  PubMed  Google Scholar 

  31. Fontaine G, Frank R, Guiraudon G, et al. Significance of intraventricular conduction disorders observed in arrhythmogenic right ventricular dysplasia. Arch Mal Coeur Vaiss. 1984;77:872-879

    CAS  PubMed  Google Scholar 

  32. Jaoude SA, Leclercq JF, Coumel P. Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. Eur Heart J. 1996;17:1717-1722

    CAS  PubMed  Google Scholar 

  33. Brugada R, Hong K, Cordeiro JM, Dumaine R. Short QT syndrome. CMAJ. 2005;173(11):1349-1354

    PubMed  Google Scholar 

  34. Hong K, Bjerregaard P, Gussak I, Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol. 2005;16:394-396

    Article  PubMed  Google Scholar 

  35. Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation. 2004;109(1):30-35

    Article  CAS  PubMed  Google Scholar 

  36. Anttonen O, Junttila MJ, Rissanen H, Reunanen A, Viitasalo M, Huikuri HV. Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation. 2007;116:714-720

    Article  CAS  PubMed  Google Scholar 

  37. Laitinen PJ, Swan H, Piippo K, Viitasalo M, Toivonen L, Kontula K. Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia. Ann Med. 2004;36(suppl 1):81-86

    Article  CAS  PubMed  Google Scholar 

  38. Postma AV, Denjoy I, Kamblock J, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet. 2005; 42:863-870

    Article  CAS  PubMed  Google Scholar 

  39. Aizawa Y, Komura S, Okada S, et al. Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). Int Heart J. 2006;47: 381-389

    Article  PubMed  Google Scholar 

  40. Fazelifar AF, Nikoo MH, Haghjoo M, et al. A patient with sick sinus syndrome, atrial flutter and bidirectional ventricular tachycardia: coincident or concomitant presentations? Cardiol J. 2007;6:585-588

    Google Scholar 

  41. Swan H, Laitinen P, Kontula K, Toivonen L. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol. 2005;16:162-166

    Article  PubMed  Google Scholar 

  42. Sumitomo N, Harada K, Nagashima M, et al. Catecholamin­ergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart. 2003;89:66-70

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Electro-Vectocardiography, ABC Foundation, São Paulo, Brazil

    Andres Perez-Riera

Authors
  1. Andres Perez-Riera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andres Perez-Riera .

Editor information

Editors and Affiliations

  1. Masonic Medical Research Laboratory, Bleecker St. 2150, Utica, 13501, U.S.A.

    Ramon Brugada

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London

About this chapter

Cite this chapter

Perez-Riera, A. (2010). Electrocardiograms Not to Miss. In: Brugada, R. (eds) Clinical Approach to Sudden Cardiac Death Syndromes. Springer, London. https://doi.org/10.1007/978-1-84882-927-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-927-5_6

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-926-8

  • Online ISBN: 978-1-84882-927-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation